Koren, M., Giugliano, R., Raal, F., Sullivan, D., Bolognese, M., Langslet, G., … OSLER, I. (2014). Efficacy and safety of longer-term administration of evolocumab (AMG 145) in patients with hypercholesterolemia: 52-week results from the Open-Label Study of Long-Term Evaluation Against LDL-C (OSLER) randomized trial. Circulation, 129(2), 234-43. https://doi.org/10.1161/CIRCULATIONAHA.113.007012 (Original work published 2014)

Gray, H., Bell-McGuinn, K., Fleming, G., Cristea, M., Xiong, H., Sullivan, D., … Martin, L. (2018). Phase I combination study of the PARP inhibitor veliparib plus carboplatin and gemcitabine in patients with advanced ovarian cancer and other solid malignancies. Gynecologic Oncology. https://doi.org/10.1016/j.ygyno.2017.12.029 (Original work published 2018)

Mao, C., Howard, T., Sullivan, D., Fu, Z., Yu, G., Parker, S., … Herrington, D. Bioinformatic Analysis of Coronary Disease Associated SNPs and Genes to Identify Proteins Potentially Involved in the Pathogenesis of Atherosclerosis. Journal of Proteomics and Genomics Research, 2(1), 1-12. https://doi.org/10.14302/issn.2326-0793.jpgr-17-1447 (Original work published 2017)

Reilly, E., Bohrer, B., Sullivan, D., Essayli, J., Farrell, N., Brown, T., … Schaumberg, K. (2021). Registered report: Initial development and validation of the eating disorders safety behavior scale. The International Journal of Eating Disorders, 54(4), 660-667. https://doi.org/10.1002/eat.23479